Mail

FLRY3.SA - Fleury S.A.

São Paulo - São Paulo Delayed Price. Currency in BRL

Fleury S.A.

Avenida General Valdomiro de Lima, 508
Jabaquara
São Paulo, SP 04344-903
Brazil
55 11 5014 7200
https://ri.fleury.com.br

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 17,500

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Jeane Mike Tsutsui	CEO & Pres of Exec. Board	N/A	N/A	N/A
Mr. Jose Antonio de Almeida Filippo	Exec. Director of Fin., Investor Relations and Legal & Member of Exec. Board	N/A	N/A	1960
Mr. Claudio Almeida Prado	Exec. Director of New Links & Member of Exec. Board	N/A	N/A	N/A
Mr. Edgar Gil Rizzatti	Medical, Technical & Process Exec. Director and Member of Exec. Board	N/A	N/A	N/A
Rodrigo Manso	Investor Relations Sr. Mang.	N/A	N/A	N/A
Mr. Fernando Aguiar Camargo	Sec.	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in BRL.

Description

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and image exam, diagnostic information, check-up and reference laboratory, genomics, clinic day, center of infusions, dental imaging exam, dental radiology, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including teleconsultations, medical, diagnostic medicine exams, and procedures; and corporate solutions and face-to-face primary care, as well as solutions for physicians with digital office and medical education. It operates 284 customer service units and 31 hospital-based units under the Labs a+, Felippe Mattoso, Lafe, Fleury, a+SP, CIP, Moacir Cunha, Vita, inlab, Weinmann, Serdil, a+ and Diagmax, a+, IRN / CPC, Diagnosis a+, a+BA, and Pretti and Bioclinic brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.

Corporate Governance

Fleury S.A.’s ISS Governance QualityScore as of June 1, 2023 is 7. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.